Netilmicin
Netilmicin is an aminoglycoside antibiotic used to treat serious bacterial infections caused by susceptible organisms, including certain Gram-negative bacteria. It works by binding to the bacterial 30S ribosomal subunit, disrupting protein synthesis and producing a bactericidal effect. Netilmicin is available primarily as an injectable formulation for systemic infections and in ophthalmic preparations in some markets. Common side effects include nausea, injection-site reactions, and changes in kidney function, while eye preparations may cause temporary irritation or discomfort. Important risks include nephrotoxicity and ototoxicity, which can affect hearing and balance, particularly with prolonged treatment, high doses, or pre-existing kidney impairment. Netilmicin should be used under medical supervision, with appropriate dose adjustment and monitoring of kidney function and, when indicated, blood drug concentrations and hearing.
Netilmicin was historically used as a respiratory medicine for the symptomatic management of certain respiratory conditions. Its former uses included:
is okay
The import of medicines into India is regulated by the Central Drugs Standard Control Organisation (CDSCO) under the Drugs and Cosmetics Act, 1940, and the Drugs and Cosmetics Rules, 1945. The regulatory requirements depend on whether the product is an active pharmaceutical ingredient (API), a finished formulation, or an unapproved medicine intended for an individual patient's treatment.
Primeera Healthcare Private Limited can provide import coordination and pharmaceutical documentation assistance for Netilmicin, subject to confirmation of its current regulatory status and eligibility for import into India.
The export of Netilmicin from India is subject to applicable requirements under the Drugs and Cosmetics Act, 1940, the Drugs and Cosmetics Rules, 1945, and relevant export, customs, and destination-country regulations. Documentation requirements depend on whether the product is an active pharmaceutical ingredient (API), a finished pharmaceutical formulation, or a medicine intended for a specific market. Export eligibility and destination-country requirements must be verified before shipment.
Primeera Healthcare Private Limited can provide pharmaceutical export documentation assistance, regulatory coordination, and shipping support for Netilmicin, subject to confirmation of its export eligibility under applicable Indian regulations and the import requirements of the destination country.
If you have any questions or need any help, contact our Support Team. We will get in touch with you within 24 hours from Monday to Friday between 9:00 and 10:00 CET.
All Trademarks and Brands that appear on the website belong to their respective owners. Primeera Healthcare does not lay any claim on them; we only provide information.
